TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26414008

Group type: EXPERIMENTAL
Intervention: Combined education with feedback (intervention)
Number of subjects: 3
Study: 24411542

Group type: EXPERIMENTAL
Intervention: Pre-rib harvest intercostal block
Number of subjects: 120

Group type: COMPARATOR
Intervention: Post-rib harvest intercostal block
Number of subjects: 120
Study: 22776874

Group type: EXPERIMENTAL
Intervention: 3 × 10 min aerobic exercise
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1 × 30 min aerobic exercise
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control
Number of subjects: 11
Study: 20701025

Group type: EXPERIMENTAL
Intervention: Digoxin (single oral dose)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Digoxin with simultaneous administration of methimazole (in 12 patients)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Methimazole treatment (in 12 patients who were re-assessed after becoming euthyroid)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (15 healthy persons)
Number of subjects: 28
Study: 18237823

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFAs) 1 g b.i.d. for 3 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no change in pre-enrollment therapy)
Number of subjects: 32
Study: 15964747

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 103
Study: 12615677

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Cerivastatin
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Simvastatin, Atorvastatin, Cerivastatin
Number of subjects: 107
Study: 11276623

Group type: EXPERIMENTAL
Intervention: Nursing instructional program
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 122
Study: 8869414

Group type: EXPERIMENTAL
Intervention: High-calcium, alkaline drinking water
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-calcium drinking water
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-calcium, protein-controlled diet
Number of subjects: 21
Study: 1505561

Group type: EXPERIMENTAL
Intervention: Trimetazidine 6 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31608833

Group type: EXPERIMENTAL
Intervention: Integrated guidelines
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Segregated guidelines
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control guidelines
Number of subjects: 162
Study: 27590465

Group type: EXPERIMENTAL
Intervention: Swedish massage therapy
Number of subjects: 18
Study: 26866774

Group type: EXPERIMENTAL
Intervention: Low interitem distance (IID; consistency tendency likely)
Number of subjects: 341

Group type: COMPARATOR
Intervention: High interitem distance (IID; consistency tendency suppressed)
Number of subjects: 341
Study: 24907640

Group type: EXPERIMENTAL
Intervention: Feldenkrais method (n=30), one 2-hour session per week for 12 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Untreated control group (n=31)
Number of subjects: 61
Study: 22074297

Group type: EXPERIMENTAL
Intervention: 0.4% mannanoligosaccharides (MOS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control diet (without MOS)
Number of subjects: 16
Study: 20486905

Group type: EXPERIMENTAL
Intervention: Everolimus (Evr) monotherapy after 10 days of cyclosporine (CsA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cyclosporine (CsA) with/without mycophenolate mofetil
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Everolimus (Evr) monotherapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 78
Study: 17464918

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash (0.2%) administered for 30 seconds before dental manipulation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no chlorhexidine mouthwash)
Number of subjects: 106
Study: 16328570

Group type: EXPERIMENTAL
Intervention: Causal proportional hazards model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional proportional hazards model
Number of subjects: 0
Study: 12386035

Group type: EXPERIMENTAL
Intervention: Intensive control of blood glucose concentration and blood pressure
Number of subjects: 0
Study: 9797106

Group type: EXPERIMENTAL
Intervention: First FISH procedure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Second FISH procedure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Third FISH procedure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: First FISH procedure (Group 2)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Second FISH procedure (Group 2)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Third FISH procedure (Group 2)
Number of subjects: 28
Study: 7619663

Group type: EXPERIMENTAL
Intervention: Buspirone (30 mg day‐1 for 4 days and 10 mg on day 5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ipsapirone (15 mg day‐1 for 4 days and 5 mg on day 5)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine (0.15 mg intravenous administration)
Number of subjects: 0
Study: 2229614

Group type: EXPERIMENTAL
Intervention: High-copper spherical-particle dental amalgam with 0.5% Pd
Number of subjects: 193

Group type: COMPARATOR
Intervention: High-copper spherical-particle dental amalgam without Pd
Number of subjects: 193
Study: 646499

Group type: EXPERIMENTAL
Intervention: Use of a Penrose drain
Number of subjects: 334

Group type: COMPARATOR
Intervention: No drain used
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Drain used
Number of subjects: 334
Study: 31505954

Group type: EXPERIMENTAL
Intervention: Hip abductor strength-based exercises (once a day for six weeks)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Quadriceps femoris strength-based exercises (control group)
Number of subjects: 82
Study: 30711291

Group type: EXPERIMENTAL
Intervention: Lithium disilicate (e.max CAD)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Zirconia-reinforced lithium silicate (Vita Suprinity)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Polymer-infiltrated ceramic (Vita Enamic)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Polymethylmethacrylate (Telio CAD)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Polymethylmethacrylate (Telio CAD) without thermomechanical fatigue
Number of subjects: 64
Study: 28218380

Group type: EXPERIMENTAL
Intervention: UCLA Activity Score
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Harris Hip Score (HHS)
Number of subjects: 38
Study: 25417130

Group type: EXPERIMENTAL
Intervention: Robot-assisted procedure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional procedure
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 23223121

Group type: EXPERIMENTAL
Intervention: Low stimulation current threshold (0.3-0.5 mA, n = 103)
Number of subjects: 205

Group type: COMPARATOR
Intervention: High stimulation current threshold (0.9-1.1 mA, n = 102)
Number of subjects: 205
Study: 21574157

Group type: EXPERIMENTAL
Intervention: Post-dilution hemodiafiltration (post-HDF)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Reverse mid-dilution hemodiafiltration (MD-HDF)
Number of subjects: 15
Study: 19593248

Group type: EXPERIMENTAL
Intervention: 7-valent conjugate pneumococcal vaccine (PnCRM7)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Control vaccine randomized communities
Number of subjects: 410
Study: 16420549

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta‐oestradiol (tE2, n = 33)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Oral micronized 17beta‐oestradiol (oE2, n = 37)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Oral micronized 17beta‐oestradiol combined with gestodene (oE2 + G, n = 33)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo (n = 49)
Number of subjects: 152
Study: 15327582

Group type: EXPERIMENTAL
Intervention: 0.5 mg kg(‐1) oral morphine sulphate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.5 mg kg(‐1) oral oxycodone hydrochloride
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of 0.25 mg kg(‐1) morphine sulphate with 0.25 mg kg(‐1) oxycodone hydrochloride
Number of subjects: 30
Study: 11151169

Group type: COMPARATOR
Intervention: Two follow-up visits (first day and one month)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Three postoperative visits (first day, one week and one month)
Number of subjects: 106
Study: 9060557

Group type: EXPERIMENTAL
Intervention: < or = 10,000/microL
Number of subjects: 78

Group type: COMPARATOR
Intervention: < or = 20,000/microL
Number of subjects: 78
Study: 8375543

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot (LA depot)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3946435

Group type: EXPERIMENTAL
Intervention: Endoscopy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Double-contrast barium meal test
Number of subjects: 96
Study: 30362457

Group type: EXPERIMENTAL
Intervention: Auditory cortex response in individuals with ASD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Auditory cortex response in NT controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation with ASD symptom severity
Number of subjects: 0
Study: 27246602

Group type: EXPERIMENTAL
Intervention: Anthelmintic treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 19
Study: 25636858

Group type: EXPERIMENTAL
Intervention: Target Inhalation Mode (TIM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Tidal Breathing Mode (TBM)
Number of subjects: 18
Study: 23066926

Group type: EXPERIMENTAL
Intervention: Immediate FAP training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Waitlist training
Number of subjects: 16
Study: 21911726

Group type: EXPERIMENTAL
Intervention: TAC (75/50/500 mg/m² every 3 weeks)
Number of subjects: 3298

Group type: COMPARATOR
Intervention: AC (60/600 mg/m² every 3 weeks) followed by docetaxel at 100 mg/m² every 3 weeks (AC>T)
Number of subjects: 3298
Study: 18159093

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/daily, n=176)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Not receiving pravastatin (n=177)
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/daily)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Not receiving pravastatin
Number of subjects: 353
Study: 16371775

Group type: EXPERIMENTAL
Intervention: Older donor corneal tissue
Number of subjects: 0

Group type: COMPARATOR
Intervention: Younger donor corneal tissue
Number of subjects: 0
Study: 14658746

Group type: EXPERIMENTAL
Intervention: High-prime condition (stereotype words associated with Yellow Peril)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Low-prime condition (neutral words)
Number of subjects: 69
Study: 11002384

Group type: EXPERIMENTAL
Intervention: STAEST margarine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: STEEST margarine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (no added stanols or sterols)
Number of subjects: 34
Study: 9113945

Group type: EXPERIMENTAL
Intervention: Low-saturated fat diet with individualized dietary counseling
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Low-saturated fat diet
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1062
Study: 1633064

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg) with intravenous frusemide (20 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Angiotensin II (1 ng kg‐1 min‐1) after captopril pretreatment
Number of subjects: 7

Group type: COMPARATOR
Intervention: Frusemide (20 mg)
Number of subjects: 7
Study: 3466465

Group type: EXPERIMENTAL
Intervention: UV-absorbing intraocular lenses (IOLs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard posterior chamber intraocular lenses (IOLs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal age-matched observers
Number of subjects: 0
Study: 30394065

Group type: EXPERIMENTAL
Intervention: PI+Smith
Number of subjects: 57

Group type: COMPARATOR
Intervention: Manual Control (MC)
Number of subjects: 57
Study: 28947790

Group type: EXPERIMENTAL
Intervention: Normal sleep
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Sleep restricted to 3 hours
Number of subjects: 86
Study: 25791143

Group type: EXPERIMENTAL
Intervention: Telehealth service model (6 sessions over 22 weeks of combined pharmacotherapy and caregiver behavior training)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Telehealth service model
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control service delivery model (treatment with PCPs augmented with telepsychiatry consultation)
Number of subjects: 223
Study: 22882647

Group type: EXPERIMENTAL
Intervention: 6 F × 24 cm Contour(TM) stent
Number of subjects: 162

Group type: COMPARATOR
Intervention: multi-length 6 F × 22-30 cm Contour VL(TM) stent
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Both stent types
Number of subjects: 162
Study: 21059663

Group type: EXPERIMENTAL
Intervention: Progressive resistive exercises for lower limbs and balance training for six weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Regular activities (control)
Number of subjects: 23
Study: 19137230

Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension
Number of subjects: 191

Group type: COMPARATOR
Intervention: Open colposuspension
Number of subjects: 191
Study: 17302515

Group type: EXPERIMENTAL
Intervention: Fortified mineral water (1000 mL/day)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Normal mineral water (control)
Number of subjects: 74
Study: 14762837

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced intraoperative ultrasonography (CE-IOUS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intraoperative ultrasonography (IOUS)
Number of subjects: 16
Study: 12588812

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radioiodine therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant human TSH and laser therapy
Number of subjects: 0
Study: 9520244

Group type: EXPERIMENTAL
Intervention: Chronic Pain Self‐Management Program (CPSMP); 12-hour intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Wait-list control group; 3-month wait
Number of subjects: 110
Study: 7927562

Group type: EXPERIMENTAL
Intervention: Pranayama (controlled breathing practice)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 3289502

Group type: EXPERIMENTAL
Intervention: OK-432 + 5-FU
Number of subjects: 97

Group type: COMPARATOR
Intervention: 5-FU
Number of subjects: 97
Study: 31967190

Group type: EXPERIMENTAL
Intervention: Juice Group (200ml carbohydrate- and protein-enriched liquid)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control Group (200ml inert solution)
Number of subjects: 80
Study: 29382403

Group type: EXPERIMENTAL
Intervention: Stigma stress at baseline
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Shame and self-contempt at baseline
Number of subjects: 186
Study: 28169879

Group type: EXPERIMENTAL
Intervention: 15-week induction/consolidation not followed by reinduction
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Pirarubicin at 25 mg/m administered 11 times throughout the treatment
Number of subjects: 563

Group type: COMPARATOR
Intervention: Standard-risk group regimen with reinduction therapy
Number of subjects: 563

Group type: COMPARATOR
Intervention: Intermediate-risk group regimen
Number of subjects: 563

Group type: COMPARATOR
Intervention: High-risk group regimen
Number of subjects: 563

Group type: COMPARATOR
Intervention: Extremely high-risk group regimen
Number of subjects: 563
Study: 25044635

Group type: EXPERIMENTAL
Intervention: Mistent(®) absorbable polymer sirolimus‐eluting stent (APSES)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Endeavor(®) zotarolimus‐eluting stent (ZES)
Number of subjects: 29

Group type: COMPARATOR
Intervention: 1st‐gen sirolimus‐eluting stent (SES)
Number of subjects: 29
Study: 23320402

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine (TDB)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl (TDF)
Number of subjects: 46
Study: 21366642

Group type: EXPERIMENTAL
Intervention: Community pharmacy intervention using a software application to data mine pharmacy dispensing records and provide educational material to patients.
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Community pharmacy intervention (same as above).
Number of subjects: 718
Study: 19052958

Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 121

Group type: COMPARATOR
Intervention: Lind fundoplication
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 121
Study: 16500579

Group type: EXPERIMENTAL
Intervention: Warfarin (International Normalized Ratio 2.5-3)
Number of subjects: 2860

Group type: COMPARATOR
Intervention: Aspirin (325 mg)
Number of subjects: 2860

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 2860

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 2860
Study: 15606957

Group type: EXPERIMENTAL
Intervention: Non-contact skin moisture measurement using near-infrared spectroscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Capacitance method
Number of subjects: 0
Study: 11335771

Group type: EXPERIMENTAL
Intervention: Classroom-based smoking cessation curriculum (n = 35)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Informational pamphlet (n = 39)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Informational pamphlet followed by classroom intervention (n = 39)
Number of subjects: 74
Study: 9272138

Group type: EXPERIMENTAL
Intervention: CODE with rhG-CSF
Number of subjects: 64

Group type: COMPARATOR
Intervention: CODE alone
Number of subjects: 64
Study: 8387607

Group type: EXPERIMENTAL
Intervention: Supportive care plus cisplatin (75 mg/m2), cyclophosphamide (400 mg/m2), and mitomycin (10 mg/m2) given intravenously at 3-week intervals
Number of subjects: 102

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 102
Study: 3065356

Group type: EXPERIMENTAL
Intervention: Transabdominal chorionic villus sampling
Number of subjects: 639

Group type: COMPARATOR
Intervention: Transcervical chorionic villus sampling
Number of subjects: 639
Study: 29690882

Group type: EXPERIMENTAL
Intervention: Evidence-based policy recommendation document
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Evidence-based policy recommendation document with support from a knowledge broker
Number of subjects: 3

Group type: COMPARATOR
Intervention: Usual practice control group
Number of subjects: 3
Study: 28870155

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (200 mg capsules self-administered vaginally daily until 36 weeks gestation or delivery)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cervical pessary (placed during vaginal examination until 36 weeks gestation or delivery)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 0
Study: 26045064

Group type: EXPERIMENTAL
Intervention: Time-averaged isofurans in the highest quartile
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Highest quartiles of hsCRP
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Highest quartiles of IL-6
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Baseline hsCRP in the highest quartiles
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Baseline IL-6 in the highest quartiles
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Baseline isofurans in the highest quartiles
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Baseline F2-isoprostanes quartile
Number of subjects: 165
Study: 23633700

Group type: EXPERIMENTAL
Intervention: 20 percent benzocaine gel
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: 10 percent benzocaine gel
Number of subjects: 576

Group type: COMPARATOR
Intervention: Vehicle gel (placebo)
Number of subjects: 576
Study: 22010225

Group type: EXPERIMENTAL
Intervention: 250 µg/kg of vitamin D(3)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control 1 (early age control)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control 2
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 2% FOS
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 4% FOS
Number of subjects: 54
Study: 18971554

Group type: EXPERIMENTAL
Intervention: Irbesartan (100 mg tablet per day)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 16711849

Group type: EXPERIMENTAL
Intervention: Global network analysis of multichannel EEGs
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Minimum spanning tree method for EEG analysis
Number of subjects: 11
Study: 14769755

Group type: EXPERIMENTAL
Intervention: Virtual bronchoscopy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Flexible bronchoscopy
Number of subjects: 20
Study: 11408881

Group type: EXPERIMENTAL
Intervention: Electric vacuum curettage
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Manual vacuum aspirator
Number of subjects: 114

Group type: COMPARATOR
Intervention: Electric vacuum curettage by residents
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Both techniques (Electric vacuum curettage and Manual vacuum aspirator)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Residents and faculty performing abortions
Number of subjects: 114
Study: 8989341

Group type: EXPERIMENTAL
Intervention: Inhaled furosemide (1 mg/kg in 2 mL of saline)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (2 mL of saline)
Number of subjects: 9
Study: 8480077

Group type: EXPERIMENTAL
Intervention: Theophylline therapy after vitamin B6 supplementation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Theophylline therapy after placebo
Number of subjects: 15
Study: 3547879

Group type: EXPERIMENTAL
Intervention: Oral metoclopramide (20 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Oral cyclosporine
Number of subjects: 14
Study: 31845112

Group type: EXPERIMENTAL
Intervention: Higher-risk youth
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower-risk youth
Number of subjects: 0